The latest from Japanese pharma, including Takeda’s big profit jump, British Linepharma’s quest to get the first ever induced abortion pill for…

Japan's pharma market is one of the world's biggest, with a value of around USD 95 billion, according to figures from the country's Ministry of…

Sheron Lin, president of Daiichi Sankyo Taiwan, elaborates on the affiliate’s tactical positioning in the region and a leading market for clinical…

Yuichi Yomasu, president of Daiichi Sankyo China, shares his first impressions of the dynamic but complex Chinese market since he assumed position ten…

Dae Jung Kim, president of Daiichi Sankyo Korea provides an insight into the rationale behind the company’s focus on the cardiovascular therapeutic…

The Thai pharmaceutical market is growing due to an aging, wealthier local population and a large medical tourism sector. International…

The president of Daiichi Sankyo France discusses the affiliate’s positioning and future strategy, the challenges for an international pharmaceutical…

Antonino Reale, who has managed Daiichi-Sankyo Italy for the last 12 years, explains the reasoning and strategy behind the company’s almost total…

The general manager of Daiichi Sankyo Turkey discusses his affiliate's expansion into a regional hub, current strategies for growth in the Turkish…

Daiichi Sankyo Thailand's managing director explains the Thai subsidiary's success under his leadership, Thailand’s untapped potential as a…

Can you give our readers a brief overview of Daiichi Sankyo in Austria as well as its market positioning and growth factors in 2012? Daiichi Sankyo…

Would you like to come back for our readers on the main milestones in Daiichi Sankyo’s development over the past few years in Turkey and how it…